Media stories about DENTSPLY SIRONA (NASDAQ:XRAY) have been trending somewhat positive on Friday, Accern reports. The research group rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. DENTSPLY SIRONA earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news stories about the medical instruments supplier an impact score of 45.8924883480628 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:
- Dental and Healthcare Consumables Grew but Missed Expectations in 2Q17 (finance.yahoo.com)
- Discussing Dentsply Sirona’s Updated 2017 Guidance (finance.yahoo.com)
- Featured Company News - NeuroMetrix Announces Issuance of New US Patent for Automated Control of Quell(R) Therapy During Sleep (finance.yahoo.com)
DENTSPLY SIRONA (NASDAQ XRAY) opened at 53.17 on Friday. The firm has a 50-day moving average price of $61.68 and a 200 day moving average price of $62.21. The firm’s market capitalization is $12.20 billion. DENTSPLY SIRONA has a one year low of $52.73 and a one year high of $65.68.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.65. The firm had revenue of $992.70 million for the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.76 earnings per share. Analysts anticipate that DENTSPLY SIRONA will post $2.72 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.66%. DENTSPLY SIRONA’s dividend payout ratio is currently -10.09%.
Several research firms recently weighed in on XRAY. BidaskClub cut DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a report on Wednesday. Zacks Investment Research cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday. HC Wainwright reissued a “buy” rating and set a $68.00 price target (down from $74.00) on shares of DENTSPLY SIRONA in a report on Monday. TheStreet cut DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday, August 9th. Finally, UBS AG reissued a “neutral” rating and set a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $66.25.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
